Researchers at the Icahn School of Medicine at Mount Sinai have discovered a way that ovarian cancer tumors manipulate their ...

Ovarian cancer is one of the most deadly cancers; 50 percent of patients die within five years of diagnosis. While ...

Study findings suggest the potential to repurpose a drug that is FDA-approved for treating asthma and eczema, to enhance ...

New study reveals how ovarian cancer shields itself from the immune system, opening doors to innovative immunotherapy methods ...

Ovarian cancer is one of the most deadly cancers; 50% of patients die within five years of diagnosis. While immunotherapy drugs such as pembrolizumab, which target the PD-1 molecule, have ...

Ladies and gentlemen, thank you for joining us today. Welcome to Compugen's Third Quarter 2024 Results Conference Call. At ...

Dr. Shannon Westin (Host), Dr. Brian Slomovitz (Guest) Dr. Shannon Westin and her guest, Dr. Brian Slomovitz discuss the article “Pembrolizumab ... from endometrial cancer is going to outnumber the ...

Keytruda (pembrolizumab) is a prescription drug ... Does Keytruda treat ovarian cancer or brain cancer such as glioblastoma? Currently, Keytruda isn’t used to treat ovarian cancer.

Compugen (CGEN) has released an update. Compugen Ltd. has announced promising data on the anti-tumor activity and safety of its triple ...

Compugen Ltd (NASDAQ:CGEN) reported encouraging data from their studies on COM701, COM902, and pembrolizumab in patients with ...

Company remains on track in late-stage, potentially registrational trials of nemvaleukin alfa, with data readouts expected in late Q1/early Q2 ...

Abrocitinib for treating moderate to severe atopic dermatitis in people aged 12 and over [ID3768] Technology appraisal guidance TBC Pembrolizumab with pemetrexed ... treating advanced ...